Hims & Hers Health Inc.正日益坚定地看好其2030年发展蓝图。该公司如今对实现至少65亿美元营收与13亿美元调整后EBITDA的远期目标,抱有愈发强烈的信心。这一雄心勃勃的规划,彰显了管理层对长期增长轨迹的笃定,以及公司战略执行力的持续强化。
Hims & Hers Health Inc.正日益坚定地看好其2030年发展蓝图。该公司如今对实现至少65亿美元营收与13亿美元调整后EBITDA的远期目标,抱有愈发强烈的信心。这一雄心勃勃的规划,彰显了管理层对长期增长轨迹的笃定,以及公司战略执行力的持续强化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.